曲美木单抗
Tremelimumab (anti-CTLA-4)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$530.00
Member price
Product Availability
3-5days
Price
$1200.00
Member price
Product Availability
3-5days
Price
$1900.00
Member price
Product Availability
3-5days
Price
$6000.00
Member price
Product Availability
3-5days
Price
$12000.00
Member price
Quantity
- +
Product Overview
Product Name Tremelimumab (anti-CTLA-4)
CAS745013-59-6
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Security information
Product details

Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.

Related literature
Related
Sorry, no related items
History
Etanercept,stock solution
Rimonabant Hydrochloride
Nolatrexed dihydrochloride
Tremelimumab (anti-CTLA-4)
DM4
Galunisertib monohydrate | LY2157299 monohydrate
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)